Connection

Daynna Wolff to United States

This is a "connection" page, showing publications Daynna Wolff has written about United States.
Connection Strength

0.085
  1. Developing a sustainable process to provide quality control materials for genetic testing. Genet Med. 2005 Oct; 7(8):534-49.
    View in: PubMed
    Score: 0.028
  2. Chromosomal microarray analysis, including constitutional and neoplastic disease applications, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2021 10; 23(10):1818-1829.
    View in: PubMed
    Score: 0.021
  3. Validation of fluorescence in situ hybridization using an analyte-specific reagent for detection of abnormalities involving the mixed lineage leukemia gene. Arch Pathol Lab Med. 2012 Jan; 136(1):47-52.
    View in: PubMed
    Score: 0.011
  4. College of American Pathologists/American College of Medical Genetics proficiency testing for constitutional cytogenomic microarray analysis. Genet Med. 2011 Sep; 13(9):765-9.
    View in: PubMed
    Score: 0.011
  5. Cytogenetic heteromorphisms: survey results and reporting practices of giemsa-band regions that we have pondered for years. Arch Pathol Lab Med. 2006 Jul; 130(7):947-9.
    View in: PubMed
    Score: 0.007
  6. HER-2 fluorescence in situ hybridization: results from the survey program of the College of American Pathologists. Arch Pathol Lab Med. 2006 Mar; 130(3):325-31.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.